Last edition
News about Global Pharma
The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products
Global Pharma | 27/02/2023 | By Sudeep Soparkar | 1303
ADCAN Pharma in Abhu Dhabi commences operations
ADCAN Pharma's factory is built on a plot of 31,000 square meters within the ICAD area
<br />
Global Pharma | 23/02/2023 | By Sudeep Soparkar | 2136
Shilpa Medicare registers Bengaluru facility with Ministry of Health, UAE
The facility is involved in the manufacturing and testing of specialized dosage forms eg. Orodispersible Films and Transdermal systems
Global Pharma | 20/02/2023 | By Sudeep Soparkar | 1276
Australia-headquartered Novotech to acquire EastHORN
The acquisition is part of Novotech's global expansion programme
Global Pharma | 17/01/2023 | By Sudeep Soparkar | 1217
The lab will be a dedicated facility for integrated discovery work streams including medicinal and synthetic chemistry, in vitro biology, and process chemistry
Global Pharma | 11/01/2023 | By Sudeep Soparkar | 1748
PIRC will be equipped with a state-of-the-art lab featuring cutting-edge technology to support the identification and development of therapeutic opportunities
Global Pharma | 09/01/2023 | By Sudeep Soparkar | 978
Polysciences creates new bioprocessing brand, Kyfora Bio
Based in Horsham, PA, Kyfora Bio will occupy a 45,000 sq ft cGMP facility with administrative offices, R&D labs, manufacturing suites
Global Pharma | 03/01/2023 | By Sudeep Soparkar | 621
Global Pharma | 30/12/2022 | By Sudeep Soparkar | 825
Advent International to pick up 50.1% in Suven Pharma for Rs 6,313 Cr
The buyout is part of the private equity firm’s plan to create a contract drug manufacturing powerhouse in India
Global Pharma | 27/12/2022 | By Sudeep Soparkar | 931
KBI Biopharma secures Swissmedic Regulatory Establishment License for Geneva facility
The license allows KBI to fully support clients in their next phases of growth and certifies KBI's manufacturing capabilities in a cGMP environment
Global Pharma | 26/12/2022 | By Sudeep Soparkar | 986
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy